Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.6300
-0.0255 (-3.89%)
At close: Mar 20, 2026
Isofol Medical AB Market Cap
Isofol Medical AB has a market cap or net worth of 204.93 million as of March 20, 2026. Its market cap has decreased by -11.77% in one year.
Market Cap
204.93M
Enterprise Value
66.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.63
Market Cap Chart
Since April 4, 2017, Isofol Medical AB's market cap has decreased from 853.32M to 204.93M, a decrease of -75.98%. That is a compound annual growth rate of -14.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 177.10M | -13.58% |
| Dec 30, 2025 | 204.93M | -42.85% |
| Dec 30, 2024 | 358.56M | 204.11% |
| Dec 29, 2023 | 117.91M | -1.35% |
| Dec 30, 2022 | 119.52M | -91.99% |
| Dec 30, 2021 | 1.49B | -36.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 262.58M |
| Mendus AB | 248.16M |
| Intervacc AB | 247.09M |
| Sprint Bioscience AB | 222.64M |
| Initiator Pharma | 210.83M |
| Xintela AB | 202.40M |
| AlzeCure Pharma AB | 198.80M |
| Magle Chemoswed Holding AB | 162.10M |